Please Wait.....
Report
Edwards Lifesciences Corporation (EW:NYSE) Strategic SWOT, PESTLE Analysis and Financial Insights - A 360 Review of Opportunities, Challenges and Risk, Corporate and ESG Strategies, Competitive Intelligence, Financial and Operational KPI's, and Recent Trends
Company Report I 2024-09-19 I 84 Pages I Quaintel Research
Report Summary
Edwards Lifesciences Corporation (EW:NYSE) Strategic SWOT, PESTLE Analysis and Financial Insights - A 360 Review of Opportunities, Challenges and Risk, Corporate and ESG Strategies, Competitive Intelligence, Financial and Operational KPI's, and Recent Trends Report is a comprehensive and easily accessible overview of Edwards Lifesciences Corporation's business operations. It provides a detailed analysis of the company's financial and strategic standing, as well as its position in the industry compared to competitors. The report includes several key features to facilitate decision-making and provide insights into the company's performance.
The report begins with in-depth information about Edwards Lifesciences Corporation including key insights, business segments, key executives, locations, products and services, historical events, corporate strategy, and management discussions. This section provides a solid foundation for understanding the company's key attributes.
Next, the report assesses Edwards Lifesciences Corporation's strategic standing through various analyses. The ESG spotlight evaluates the company's environmental, social, and governance performance, providing insights into its sustainability efforts and ethical practices. The SWOT analysis examines the company's internal strengths and weaknesses, as well as external opportunities and threats. The PESTLE analysis evaluates the external factors impacting the company's operations and market environment. Additionally, By integrating these strategic analyses, the report offers a comprehensive understanding of Edwards Lifesciences Corporation's overall strategic standing and supports informed decision-making and strategic planning.
The report also covers Edwards Lifesciences Corporation's financial analysis basis of latest income statement, balance sheet, and cash flow statement. Key financial ratios related to profitability, asset turnover, credit, market, and long-term solvency are outlined, providing guidance for investment decisions. Furthermore, the report compares Edwards Lifesciences Corporation's financial parameters with those of its competitors, offering a unique analysis of the competitive landscape. This information helps manage the business environment and improve sales activities by gaining insight into competitors' operations.
Finally, the report includes recent news and deal activities undertaken by Edwards Lifesciences Corporation enhancing awareness of the company's business trends, growth perspectives, and more.
Key Highlights
Edwards Lifesciences Corporation operates as a medical technology company that provides products and technologies for structural heart disease, and critical care and surgical monitoring. Edwards Lifesciences Corporation operates in two main business segments: Transcatheter Heart Valve Therapy and Surgical Structural Heart. The Transcatheter Heart Valve Therapy segment focuses on minimally invasive heart valve replacement while the Surgical Structural Heart segment provides surgical heart valve replacement products and repair products.
Edwards Lifesciences Corporation offers a range of products and services including:
- Transcatheter heart valve replacement products for minimally invasive heart valve replacement
- Transcatheter heart valve repair products to treat mitral and tricuspid valve diseases
- Surgical structural heart solutions like tissue replacement heart valves and heart valve repair products
- Critical care solutions such as advanced hemodynamic monitoring systems and software to predict hypotension
- Products distributed through direct sales force and independent distributors
Founded in 1958, the company is headquartered in Irvine, California, United States.
Edwards Lifesciences Corporation in the News:-
- 03-Sep-2024 - Edwards Lifesciences Completes Sale of Critical Care
- 31-Aug-2024 - First All-Female TAVI Trial Shows Excellent Outcomes for Women Receiving Edwards Valves
- 31-Aug-2024 - First All-Female TAVI Trial Shows Excellent Outcomes for Women Receiving Edwards Valves
- 21-Aug-2024 - Edwards Lifesciences to Present at the 2024 Wells Fargo Healthcare Conference
- 21-Aug-2024 - Edwards Lifesciences to Present at the 2024 Wells Fargo Healthcare Conference
Scope
- Tactical Analysis:- Various strategic frameworks to gain insights into a company's competitive position and operational environment. These analytical tools assist in identifying competitive advantages, potential risks, and areas for improvement and efficiency, enabling companies to make informed tactical decisions.
- Business Strategy:- Contributes to shaping the company's overall direction, goals, and decision-making processes, ensuring long-term success and alignment with stakeholder expectations.
- Financial Position:- Provide valuable information on the financial performance and investor sentiment surrounding the company. Indicating the level of confidence and expectations in the company's future prospects. These components collectively contribute to understanding the financial health and market perception of the company.
- Company Fundamentals:- These fundamentals offer valuable insights into the company's history, operations, leadership, and geographical presence, aiding in a comprehensive understanding of the organization.
- Competitive Landscape:- An identification of the company's main competitors, providing insights into the competitive landscape it operates in.
Reasons to Buy
- Comprehensive Understanding of the Edwards Lifesciences Corporation's internal and external factors through SWOT analysis, PESTLE analysis, Financial Analysis, and Competitors Benchmarking.
- Strive Strategic Decision Making with various analyses and identifying potential customers and suppliers.
- Mitigate Risk with help of thorough analysis of internal and external factors. Furthermore, develop strategies and contingency plans to address these challenges and minimize their impact on business operations.
- Competitive Benchmarking will help to gain a competitive advantage by understanding industry trends, customer preferences, and best practices.
- Financial Performance Evaluation provides crucial insights into key financial ratios and trends, supporting better financial decision-making and resource allocation.
- Valuable insights from the report enable investors and partners to make informed decisions regarding potential Collaborations, Investments, or Partnerships with the company.
Additionally, available deep-dive analysis on the company Edwards Lifesciences Corporation:
- Edwards Lifesciences Corporation Value Chain Analysis
- Edwards Lifesciences Corporation Porter's Five Forces Analysis
- Edwards Lifesciences Corporation VRIO Analysis
- Edwards Lifesciences Corporation BCG Analysis
- Edwards Lifesciences Corporation Segmentation, Targeting and Positioning (STP) Analysis
- Edwards Lifesciences Corporation Ansoff Matrix Analysis
Table of Contents
COMPANY EXECUTIVE SUMMARY 1
Table of Contents 2
Tables 5
Charts 6
Edwards Lifesciences Corporation - Key Company Facts 7
Edwards Lifesciences Corporation - Company Description 8
Edwards Lifesciences Corporation - Top Executives 9
Edwards Lifesciences Corporation- Head Office & Locations 10
Head Office - Country 10
Edwards Lifesciences Corporation - Company's Mission and Vision 11
Mission 11
Edwards Lifesciences Corporation - Corporate Strategy 12
Edwards Lifesciences Corporation - Business Description 16
Transcatheter Aortic Valve Replacement 17
Transcatheter Mitral and Tricuspid Therapies 17
Surgical Structural Heart 17
Critical Care 17
Edwards Lifesciences Corporation - ESG Spotlight 19
Environment 19
Social 20
Corporate Governance 20
Edwards Lifesciences Corporation - SWOT Analysis 21
Overview 21
Strengths 23
Weaknesses 25
Opportunities 26
Threats 29
Edwards Lifesciences Corporation - PESTLE Analysis 32
Overview 32
Political Factors 34
Economic Factors 35
Social Factors 36
Technological Factors 37
Legal Factors 38
Environmental Factors 39
Edwards Lifesciences Corporation - Financial Deep Dive 41
Share Price Trend - Sep-2023to Sep-2024 (Average Share Closing Price) 41
Profit and Loss Statement 43
Summary of Profit and Loss Statement 43
Balance Sheet 45
Summary of Balance Sheet 45
Cash Flow Statement 47
Summary of Cash Flow Statement 47
Key Financial Ratio Analysis 49
Edwards Lifesciences Corporation - Ratio Charts 50
Activity Ratio Charts 50
Growth Ratios Charts 51
Leverage Ratio Charts 52
Liquidity Ratio Charts 52
Profitability Ratio Charts 54
Competing Players 55
Snapshot of Competing Players 56
Abbott Laboratories 56
Key Company Facts 56
Company Description 56
Snapshot of Competing Players 58
Boston Scientific Corporation 58
Key Company Facts 58
Company Description 58
Snapshot of Competing Players 60
ICU Medical Inc. 60
Key Company Facts 60
Company Description 60
Snapshot of Competing Players 62
Medtronic plc 62
Key Company Facts 62
Company Description 62
Snapshot of Competing Players 64
Siemens Healthineers AG 64
Key Company Facts 64
Company Description 64
Edwards Lifesciences Corporation - In the News 67
03-Sep-2024- Edwards Lifesciences Completes Sale of Critical Care 67
31-Aug-2024- First All-Female TAVI Trial Shows Excellent Outcomes for Women Receiving Edwards Valves 68
31-Aug-2024- First All-Female TAVI Trial Shows Excellent Outcomes for Women Receiving Edwards Valves 68
21-Aug-2024- Edwards Lifesciences to Present at the 2024 Wells Fargo Healthcare Conference 70
21-Aug-2024- Edwards Lifesciences to Present at the 2024 Wells Fargo Healthcare Conference 70
24-Jul-2024- Edwards Lifesciences Reports Second Quarter Results 71
21-Jul-2024- Edwards Lifesciences Expands Structural Heart Portfolio With Acquisitions of JenaValve and Endotronix 75
Edwards Lifesciences Corporation- Key Deals 76
03-Sep-2024 - Edwards Lifesciences Completes Sale of Critical Care 76
Appendix 77
Definitions 77
SWOT Analysis 77
PESTLE Analysis 77
Value Chain Analysis 77
ESG Spotlight 77
Financial Deep Dive 77
Financial Ratios - 78
Activity Ratios 78
Growth Ratios 79
Leverage Ratios 80
Liquidity Ratios 81
Market Ratios 82
Profitability Ratios 82
Research Methodology 83
Disclaimer 84
Contact Us 84
Tables
Table 1: Edwards Lifesciences Corporation - Company Facts
Table 2: Edwards Lifesciences Corporation - Top Executives
Table 3: Edwards Lifesciences Corporation - Share Price Trend - Sep-2023 to Sep-2024
Table 4: Edwards Lifesciences Corporation- Ratio Analysis - 2020-2023
Table 5: Edwards Lifesciences Corporation -Competing Players
Charts
Figure 1: Edwards Lifesciences Corporation- SWOT Analysis 22
Figure 2: Edwards Lifesciences Corporation - PESTLE Analysis 33
Figure 3: Edwards Lifesciences Corporation - Average Share Price Trend - Sep-2023 to Sep-2024 42
Figure 4: Edwards Lifesciences Corporation - Profit and Loss Statement - 2020-2023 44
Figure 5: Edwards Lifesciences Corporation - Balance Sheet - 2020-2023 46
Figure 6: Edwards Lifesciences Corporation - Cash Flow Statement 2020-2023 48
Figure 7: Edwards Lifesciences Corporation - Activity Ratio Charts 50
Figure 8: Edwards Lifesciences Corporation - Growth Ratio Charts (Value %) 51
Figure 9: Edwards Lifesciences Corporation - Leverage Ratio Charts 52
Figure 10: Edwards Lifesciences Corporation - Liquidity Ratio Charts 53
Figure 11: Edwards Lifesciences Corporation - Profitability Ratio Charts (Value %) 54
Figure 12: Competing Players - Abbott Laboratories - Key Financials 57
Figure 13: Competing Players - Boston Scientific Corporation - Key Financials 59
Figure 14: Competing Players - ICU Medical Inc. - Key Financials 61
Figure 15: Competing Players - Medtronic plc - Key Financials 63
Figure 16: Competing Players - Siemens Healthineers AG - Key Financials 66
- Not Sure / Need Reassuring
- Confirm Content
-
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
-
- Sample Pages
-
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Check for Alternatives
-
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
-
- Confirm Content
- Prices / Formats / Delivery
- Prices
-
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Discounts
-
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Available Currencies
-
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
-
- Licenses
-
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Global Site License
-
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Formats
-
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
-
- Delivery
-
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
-
- Shipping Charges
-
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
-
- Prices
- Ordering
- By Credit Card
-
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
-
- By Money Transfer
-
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
-
- By Credit Card
- Security
- Website security
-
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
-
- Credit Card Security
-
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.
-
- Website security